Wuhan General Group (China), Inc. announced that it has agreed in principle to the terms and conditions regarding the previously announced acquisition of MJ MedTech, which will be concluded by December 15, 2018. In addition, the Company's Board of Directors has nominated Jeff Robinson as Chief Executive Officer (CEO) to assume position on the aforementioned date and serve as Chairman of Wuhan's Board. Wuhan also announced that Mr. Kamaneh, currently CEO and Chairman of the Wuhan Board of Directors, will remain a member of the Board, during this reorganization, as a trusted advisor providing his time and support in overseeing the acquisition that will bring more value to the shareholders in growing the business and strengthening the company management.